{"id":"W2911723829","doi":"10.1007/s40264-019-00797-3","title":"Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs","year":2019,"lang":"en","type":"article","venue":"Drug Safety","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"Janssen Research and Development","keywords":"Medicine; Ustekinumab; Psoriatic arthritis; Psoriasis; Placebo; Internal medicine; Psoriasis Area and Severity Index; Methotrexate; Dermatology; Dosing; Gastroenterology; Adalimumab; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05513352,0.0006549041,0.001853314,0.001895897,0.0002726296,0.001919791,0.0007277285,0.0005757476,0.001523472],"category_scores_gemma":[0.03286437,0.0004075226,0.003827735,0.00246528,0.0006194456,0.001047872,0.00110366,0.000878717,0.0001906838],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001033354,"about_ca_system_score_gemma":0.002841489,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006393684,"about_ca_topic_score_gemma":0.001116659,"domain_scores_codex":[0.9626808,0.02868964,0.00182993,0.001322543,0.004682049,0.0007949898],"domain_scores_gemma":[0.9461976,0.02398435,0.02081945,0.003624829,0.003799225,0.001574504],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1015858,0.003215109,0.5137351,0.00232341,0.02271726,0.00006341675,0.0003402302,0.009594641,0.005474181,0.0006577705,0.001818633,0.3384744],"study_design_scores_gemma":[0.01417857,0.07241026,0.8606485,0.0007554196,0.02260655,0.0003002406,0.0002216809,0.01342813,0.006282176,0.001142029,0.007940722,0.00008577869],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.960697,0.025189,0.006622067,0.0004816151,0.00004214629,0.001849324,0.002373207,0.0001197576,0.002625903],"genre_scores_gemma":[0.9893193,0.003310756,0.003007439,0.0002780664,0.00007427989,0.0006369855,0.003016237,0.00002970959,0.0003273119],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05513352,"threshold_uncertainty_score":0.2915774,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01842427804209179,"score_gpt":0.3197942799163208,"score_spread":0.301370001874229,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}